Back to Search Start Over

Aging and hypertension decrease endothelial NO-related dilating function and gamma-glutamyl transferase activity but notS-nitrosoglutathione-induced aortic vasodilation

Authors :
Pierre Leroy
Fatima Dahboul
Caroline Perrin-Sarrado
Isabelle Lartaud
Cibles thérapeutiques, formulation et expertise pré-clinique du médicament (CITHEFOR)
Université de Lorraine (UL)
Source :
Fundamental and Clinical Pharmacology, Fundamental and Clinical Pharmacology, Wiley, 2018, 32 (2), pp.134-140. ⟨10.1111/fcp.12347⟩
Publication Year :
2018
Publisher :
Wiley, 2018.

Abstract

International audience; S‐nitrosoglutathione (GSNO), which is involved in the transport and the storage of NO, induces vasorelaxation. It requires gamma‐glutamyl transferase (GGT), an enzyme present on the endothelium, to transfer NO into the cell. We evaluated whether aging and hypertension, which induce NO‐related dilating dysfunction, are associated with decreased vascular GGT activity and modify the vasorelaxant effect of GSNO. Thoracic aortic rings isolated from male spontaneous hypertensive rats (SHR) and Wistar‐Kyoto rats (WKY) aged 20–22 (adult) or 57–60 weeks (mature) were preconstricted with phenylephrine, then submitted to concentration‐vasorelaxant response curves (maximal response: Emax; pD2) to GSNO and carbachol (the latter to measure NO‐related dilating function). GGT activity was measured using chromogenic substrate. Both aging and hypertension lowered Emax values for carbachol (Emax −8% in adult SHR, −42% in mature SHR vs. age‐matched WKY, page and phypertension < 0.05) demonstrating NO‐related dilating dysfunction. Aortic GGT activity also decreased with aging and hypertension (−22% in adult and −75%, reaching 3 nmol/min/g of tissue, in mature SHR vs. 12 in age‐matched WKY and 23 in adult WKY, page and phypertension < 0.05). The pD2 values of GSNO were similar in mature SHR and WKY but higher in adult SHR (pinteraction < 0.05). Aging in hypertensive rats decreased NO‐related vasorelaxant function and vascular GGT activity, but did not lower the vasorelaxant response to GSNO. This opens perspectives for GSNO‐based therapeutics restoring nitric oxide bioavailability and vascular protection in a context of endothelial dysfunction.

Details

ISSN :
07673981 and 14728206
Volume :
32
Database :
OpenAIRE
Journal :
Fundamental & Clinical Pharmacology
Accession number :
edsair.doi.dedup.....b3d31eb4bb0073cf5781af9df94b0a0c
Full Text :
https://doi.org/10.1111/fcp.12347